Global Single-cell Analysis Market by Application (Stem Cell, IVF, Cancer), by Product (Instruments, Consumables) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global single-cell analysis market was valued at USD2.2 billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 15.0% between 2021 and 2028. The market's growth can be attributed to a number of factors, including an increase in government funding and investments in medical diagnostics research, the availability of technically advanced products and increasing adoption of single-cell analysis device.

The development of single-cell amplification technology and manipulation techniques has allowed for high throughput technologies to be used in assays. This has resulted in revenue growth. In addition, the rapid development of microfluidic devices has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field.

Technological advances in sequencing techniques have transformed the landscape of single cell omics research activities. A large number of samples have been processed due to significant advances in sequencing reproducibility and declining costs.

High-throughput machinery has been introduced to meet the increasing demand for analytical tools. Many innovations have resulted in the introduction of new features, such as increased sensitivity, accuracy, efficiency, and utilization of scarce samples. Key players are investing heavily in solutions that will create a lucrative revenue stream in the near future.

Due to the ongoing epidemic of COVID-19, single-cell analysis has been adopted in virology research. These techniques are being used by researchers to study the immune profiles infected patients. In a January 2021 study, researchers from China did a high-dimensional single cell analysis to determine the peripheral immune response to COVID-19 infection.

Product Insights

Consumables dominated the market, accounting for the largest revenue share at 57.1% in 2020. This was due to high usability and frequent purchases of reagents and large-scale adoptions of beads and growing demand for assay kit kits. Segment growth is being driven by an increase in target diseases and constant demand for consumables for assays.

Reagents are consumables that are used extensively in cell analysis assays. Therefore, the demand for them is high. There are many options for these reagents. They can be purchased in many forms, including probes, markers and phenotyping agent. The market generates revenue through the purchase and adoption of reagents.

Installing new instruments or replacing old ones led to increased revenue for the instruments segment. The market saw substantial revenue thanks to the automation of instruments.

Application Insights

In 2020, the cancer segment was the dominant market. It accounted for more than 30% of the total revenue. Single-cell analysis has been proven to be useful in the prior diagnosis of cancer cells. This segment is driving. These techniques can easily identify cell types, mutation rates, and conditions for their proliferation.

A substantial number of research organizations are involved in single-cell genomics or proteomics evaluations for various therapeutic areas, such as neuroscience and cancer. This has led to an increase in single-cell analysis methods being used in diagnostics and therapeutics.

Stem cell therapies are becoming more popular, which is good news for single-cell analysis. Stem cell therapies have many applications that are expanding the field of stem cell genomics and proteomics. Single-cell analysis techniques are being adopted more frequently in therapies such as hair regeneration, bone marrow transplant, or organ transplants.

Workflow insights

Single-cell isolation and library prep dominated the market, accounting for 25.8% of the total revenue in 2020. Due to the large number of single-cell applications, there is a high demand for cell isolation products (kits or reagents). A large number of companies offer products in this market, which in turn can increase revenue growth.

The downstream analysis segment, on the other hand is growing rapidly due to technological advances such as the next-generation sequencing that allows for the analysis of cell expressions. The market is also witnessing an increase in the use of machine learning and artificial Intelligence for data analysis.

Many computational methods have been created and are currently being used due to their success rates, flexibility, scalability and high success rates. This would encourage market growth as the demand for data analysis tools is high.

End-use Insights

The market was dominated by academic and research labs in 2020. They accounted for over 70% of the total revenue. Research settings are increasingly using single-cell analysis technology. A large number of research projects in universities using single-cell analysis techniques has led to increased use of single-cell analyses in research settings.

Another key driver of segment growth is the advent spatial genomics, which accelerates single-cell analysis in research settings. Researchers at academic institutions are involved in the assessment of spatial heterogeneity in gene expression profiles at single cells. Neuroscientists can also use single-cell transcriptomics to better understand the cell types that make up the brain.

Technological advances such as microfluidics have led to increased adoption of single cell analysis by pharmaceutical and biotechnology companies. The market will be further impacted by the increasing use of genomic technologies for drug development. Numerous pharma companies have made significant investments in genomics to gain access to different genomics databases.

Regional Insights

North America was the dominant market for single-cell analysis in 2020, accounting for 35.0% of the total revenue. This is due to factors like high government funding, rising personal health expenditures, better awareness, rapid adoption of new analytical techniques and skilled personnel.

The United States is the main contributor to North America's dominance. The market is driven by a highly developed healthcare infrastructure, increasing spending on personalized medicine, increased awareness amongst citizens and an increase in private and government funding for research projects.

The demand for diagnostic tools has increased in Asia Pacific over the last few years due to factors like the growing medical tourism industry, the rapidly developing healthcare infrastructure and rising disposable income. This market will be driven by the concentrated efforts of the regional players and will account for the highest expected CAGR during the forecast period.

Market Share Insights & Key Companies

These companies are focusing on developing innovative products that meet consumer needs. SeqWell Inc., for single-cell RNA sequence, launched the plexWell Single Cell Rapid Kit in February 2021. It's used to simplify the preparation of NGS library libraries. In February 2021, the company signed a distribution deal with CELLINK AB for the commercialization and expansion of its products outside the U.S. These company initiatives will likely increase market competition.

These diagnostic techniques have led to a steady growth in this market. Early diagnosis is becoming more important due to the increasing prevalence of genetic disorders. Emerging players have the chance to tap into lucrative markets that are not yet being explored. The market for single-cell analysis is dominated by the following players:

• Thermo Fisher Scientific Inc.

• QIAGEN NV

• Bio-Rad Laboratories Inc.

• Illumina Inc.

• Merck Millipore

• Becton

• Dickinson & Company

• Fluidigm Corporation

• 10x Genomics, Inc.

• BGI

• Novogene Corporation

Up Market Research published a new report titled “Single-cell Analysis Market research report which is segmented by Application (Stem Cell, IVF, Cancer), by Product (Instruments, Consumables), By Players/Companies Novogene Corporation, Illumina Inc, QIAGEN NV, Fluidigm Corporation, Becton, Thermo Fisher Scientific Inc, 10x Genomics Inc, Merck Millipore, BGI, Bio-Rad Laboratories Inc, Dickinson & Company”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Single-cell Analysis Market Report Segments:

The market is segmented by Application (Stem Cell, IVF, Cancer), by Product (Instruments, Consumables).

Single-cell Analysis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Single-cell Analysis Market

Overview of the regional outlook of the Single-cell Analysis Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Single-cell Analysis Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Single-cell Analysis Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Stem Cell

                2. IVF

                3. Cancer

                1. Instruments

                2. Consumables

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Single-cell Analysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Single-cell Analysis Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.